Global Polyvalent Antivenom Supply, Demand and Key Producers, 2023-2029

Page: 106

Published Date: 03 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Polyvalent Antivenom market size is expected to reach $ 779.6 million by 2029, rising at a market growth of 4.0% CAGR during the forecast period (2023-2029).

CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

This report studies the global Polyvalent Antivenom production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Polyvalent Antivenom, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Polyvalent Antivenom that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Polyvalent Antivenom total production and demand, 2018-2029, (K Units)
Global Polyvalent Antivenom total production value, 2018-2029, (USD Million)
Global Polyvalent Antivenom production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Polyvalent Antivenom consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Polyvalent Antivenom domestic production, consumption, key domestic manufacturers and share
Global Polyvalent Antivenom production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Polyvalent Antivenom production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Polyvalent Antivenom production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Polyvalent Antivenom market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts and Bharat Serums and Vaccines, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Polyvalent Antivenom market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Polyvalent Antivenom Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Polyvalent Antivenom Market, Segmentation by Type
Antiviral Toxin-based Antivenom
Anti - Neurotoxic Antivenom
Anti - Mixed Venom Antivenom

Global Polyvalent Antivenom Market, Segmentation by Application
Non-profit Institutions
Hospitals and Clinic

Companies Profiled:
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm

Key Questions Answered
1. How big is the global Polyvalent Antivenom market?
2. What is the demand of the global Polyvalent Antivenom market?
3. What is the year over year growth of the global Polyvalent Antivenom market?
4. What is the production and production value of the global Polyvalent Antivenom market?
5. Who are the key producers in the global Polyvalent Antivenom market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Polyvalent Antivenom Introduction
    1.2 World Polyvalent Antivenom Supply & Forecast
        1.2.1 World Polyvalent Antivenom Production Value (2018 & 2022 & 2029)
        1.2.2 World Polyvalent Antivenom Production (2018-2029)
        1.2.3 World Polyvalent Antivenom Pricing Trends (2018-2029)
    1.3 World Polyvalent Antivenom Production by Region (Based on Production Site)
        1.3.1 World Polyvalent Antivenom Production Value by Region (2018-2029)
        1.3.2 World Polyvalent Antivenom Production by Region (2018-2029)
        1.3.3 World Polyvalent Antivenom Average Price by Region (2018-2029)
        1.3.4 North America Polyvalent Antivenom Production (2018-2029)
        1.3.5 Europe Polyvalent Antivenom Production (2018-2029)
        1.3.6 China Polyvalent Antivenom Production (2018-2029)
        1.3.7 Japan Polyvalent Antivenom Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Polyvalent Antivenom Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Polyvalent Antivenom Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Polyvalent Antivenom Demand (2018-2029)
    2.2 World Polyvalent Antivenom Consumption by Region
        2.2.1 World Polyvalent Antivenom Consumption by Region (2018-2023)
        2.2.2 World Polyvalent Antivenom Consumption Forecast by Region (2024-2029)
    2.3 United States Polyvalent Antivenom Consumption (2018-2029)
    2.4 China Polyvalent Antivenom Consumption (2018-2029)
    2.5 Europe Polyvalent Antivenom Consumption (2018-2029)
    2.6 Japan Polyvalent Antivenom Consumption (2018-2029)
    2.7 South Korea Polyvalent Antivenom Consumption (2018-2029)
    2.8 ASEAN Polyvalent Antivenom Consumption (2018-2029)
    2.9 India Polyvalent Antivenom Consumption (2018-2029)

3 World Polyvalent Antivenom Manufacturers Competitive Analysis
    3.1 World Polyvalent Antivenom Production Value by Manufacturer (2018-2023)
    3.2 World Polyvalent Antivenom Production by Manufacturer (2018-2023)
    3.3 World Polyvalent Antivenom Average Price by Manufacturer (2018-2023)
    3.4 Polyvalent Antivenom Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Polyvalent Antivenom Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Polyvalent Antivenom in 2022
        3.5.3 Global Concentration Ratios (CR8) for Polyvalent Antivenom in 2022
    3.6 Polyvalent Antivenom Market: Overall Company Footprint Analysis
        3.6.1 Polyvalent Antivenom Market: Region Footprint
        3.6.2 Polyvalent Antivenom Market: Company Product Type Footprint
        3.6.3 Polyvalent Antivenom Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Polyvalent Antivenom Production Value Comparison
        4.1.1 United States VS China: Polyvalent Antivenom Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Polyvalent Antivenom Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Polyvalent Antivenom Production Comparison
        4.2.1 United States VS China: Polyvalent Antivenom Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Polyvalent Antivenom Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Polyvalent Antivenom Consumption Comparison
        4.3.1 United States VS China: Polyvalent Antivenom Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Polyvalent Antivenom Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Polyvalent Antivenom Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Polyvalent Antivenom Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Polyvalent Antivenom Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Polyvalent Antivenom Production (2018-2023)
    4.5 China Based Polyvalent Antivenom Manufacturers and Market Share
        4.5.1 China Based Polyvalent Antivenom Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Polyvalent Antivenom Production Value (2018-2023)
        4.5.3 China Based Manufacturers Polyvalent Antivenom Production (2018-2023)
    4.6 Rest of World Based Polyvalent Antivenom Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Polyvalent Antivenom Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Polyvalent Antivenom Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Polyvalent Antivenom Production (2018-2023)

5 Market Analysis by Type
    5.1 World Polyvalent Antivenom Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Antiviral Toxin-based Antivenom
        5.2.2 Anti - Neurotoxic Antivenom
        5.2.3 Anti - Mixed Venom Antivenom
    5.3 Market Segment by Type
        5.3.1 World Polyvalent Antivenom Production by Type (2018-2029)
        5.3.2 World Polyvalent Antivenom Production Value by Type (2018-2029)
        5.3.3 World Polyvalent Antivenom Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Polyvalent Antivenom Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Non-profit Institutions
        6.2.2 Hospitals and Clinic
    6.3 Market Segment by Application
        6.3.1 World Polyvalent Antivenom Production by Application (2018-2029)
        6.3.2 World Polyvalent Antivenom Production Value by Application (2018-2029)
        6.3.3 World Polyvalent Antivenom Average Price by Application (2018-2029)

7 Company Profiles
    7.1 CSL
        7.1.1 CSL Details
        7.1.2 CSL Major Business
        7.1.3 CSL Polyvalent Antivenom Product and Services
        7.1.4 CSL Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 CSL Recent Developments/Updates
        7.1.6 CSL Competitive Strengths & Weaknesses
    7.2 Merck
        7.2.1 Merck Details
        7.2.2 Merck Major Business
        7.2.3 Merck Polyvalent Antivenom Product and Services
        7.2.4 Merck Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Merck Recent Developments/Updates
        7.2.6 Merck Competitive Strengths & Weaknesses
    7.3 BTG
        7.3.1 BTG Details
        7.3.2 BTG Major Business
        7.3.3 BTG Polyvalent Antivenom Product and Services
        7.3.4 BTG Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 BTG Recent Developments/Updates
        7.3.6 BTG Competitive Strengths & Weaknesses
    7.4 Pfizer
        7.4.1 Pfizer Details
        7.4.2 Pfizer Major Business
        7.4.3 Pfizer Polyvalent Antivenom Product and Services
        7.4.4 Pfizer Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Pfizer Recent Developments/Updates
        7.4.6 Pfizer Competitive Strengths & Weaknesses
    7.5 Haffkine Bio-Pharmaceutical
        7.5.1 Haffkine Bio-Pharmaceutical Details
        7.5.2 Haffkine Bio-Pharmaceutical Major Business
        7.5.3 Haffkine Bio-Pharmaceutical Polyvalent Antivenom Product and Services
        7.5.4 Haffkine Bio-Pharmaceutical Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
        7.5.6 Haffkine Bio-Pharmaceutical Competitive Strengths & Weaknesses
    7.6 Rare Disease Therapeutics
        7.6.1 Rare Disease Therapeutics Details
        7.6.2 Rare Disease Therapeutics Major Business
        7.6.3 Rare Disease Therapeutics Polyvalent Antivenom Product and Services
        7.6.4 Rare Disease Therapeutics Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Rare Disease Therapeutics Recent Developments/Updates
        7.6.6 Rare Disease Therapeutics Competitive Strengths & Weaknesses
    7.7 Flynn Pharma
        7.7.1 Flynn Pharma Details
        7.7.2 Flynn Pharma Major Business
        7.7.3 Flynn Pharma Polyvalent Antivenom Product and Services
        7.7.4 Flynn Pharma Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Flynn Pharma Recent Developments/Updates
        7.7.6 Flynn Pharma Competitive Strengths & Weaknesses
    7.8 Vins Bioproducts
        7.8.1 Vins Bioproducts Details
        7.8.2 Vins Bioproducts Major Business
        7.8.3 Vins Bioproducts Polyvalent Antivenom Product and Services
        7.8.4 Vins Bioproducts Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Vins Bioproducts Recent Developments/Updates
        7.8.6 Vins Bioproducts Competitive Strengths & Weaknesses
    7.9 Bharat Serums and Vaccines
        7.9.1 Bharat Serums and Vaccines Details
        7.9.2 Bharat Serums and Vaccines Major Business
        7.9.3 Bharat Serums and Vaccines Polyvalent Antivenom Product and Services
        7.9.4 Bharat Serums and Vaccines Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Bharat Serums and Vaccines Recent Developments/Updates
        7.9.6 Bharat Serums and Vaccines Competitive Strengths & Weaknesses
    7.10 Serum Biotech
        7.10.1 Serum Biotech Details
        7.10.2 Serum Biotech Major Business
        7.10.3 Serum Biotech Polyvalent Antivenom Product and Services
        7.10.4 Serum Biotech Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Serum Biotech Recent Developments/Updates
        7.10.6 Serum Biotech Competitive Strengths & Weaknesses
    7.11 MicroPharm
        7.11.1 MicroPharm Details
        7.11.2 MicroPharm Major Business
        7.11.3 MicroPharm Polyvalent Antivenom Product and Services
        7.11.4 MicroPharm Polyvalent Antivenom Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 MicroPharm Recent Developments/Updates
        7.11.6 MicroPharm Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Polyvalent Antivenom Industry Chain
    8.2 Polyvalent Antivenom Upstream Analysis
        8.2.1 Polyvalent Antivenom Core Raw Materials
        8.2.2 Main Manufacturers of Polyvalent Antivenom Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Polyvalent Antivenom Production Mode
    8.6 Polyvalent Antivenom Procurement Model
    8.7 Polyvalent Antivenom Industry Sales Model and Sales Channels
        8.7.1 Polyvalent Antivenom Sales Model
        8.7.2 Polyvalent Antivenom Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Polyvalent Antivenom Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Polyvalent Antivenom Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Polyvalent Antivenom Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Polyvalent Antivenom Production Value Market Share by Region (2018-2023)
    Table 5. World Polyvalent Antivenom Production Value Market Share by Region (2024-2029)
    Table 6. World Polyvalent Antivenom Production by Region (2018-2023) & (K Units)
    Table 7. World Polyvalent Antivenom Production by Region (2024-2029) & (K Units)
    Table 8. World Polyvalent Antivenom Production Market Share by Region (2018-2023)
    Table 9. World Polyvalent Antivenom Production Market Share by Region (2024-2029)
    Table 10. World Polyvalent Antivenom Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Polyvalent Antivenom Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Polyvalent Antivenom Major Market Trends
    Table 13. World Polyvalent Antivenom Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Polyvalent Antivenom Consumption by Region (2018-2023) & (K Units)
    Table 15. World Polyvalent Antivenom Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Polyvalent Antivenom Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Polyvalent Antivenom Producers in 2022
    Table 18. World Polyvalent Antivenom Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Polyvalent Antivenom Producers in 2022
    Table 20. World Polyvalent Antivenom Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Polyvalent Antivenom Company Evaluation Quadrant
    Table 22. World Polyvalent Antivenom Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Polyvalent Antivenom Production Site of Key Manufacturer
    Table 24. Polyvalent Antivenom Market: Company Product Type Footprint
    Table 25. Polyvalent Antivenom Market: Company Product Application Footprint
    Table 26. Polyvalent Antivenom Competitive Factors
    Table 27. Polyvalent Antivenom New Entrant and Capacity Expansion Plans
    Table 28. Polyvalent Antivenom Mergers & Acquisitions Activity
    Table 29. United States VS China Polyvalent Antivenom Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Polyvalent Antivenom Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Polyvalent Antivenom Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Polyvalent Antivenom Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Polyvalent Antivenom Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Polyvalent Antivenom Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Polyvalent Antivenom Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Polyvalent Antivenom Production Market Share (2018-2023)
    Table 37. China Based Polyvalent Antivenom Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Polyvalent Antivenom Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Polyvalent Antivenom Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Polyvalent Antivenom Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Polyvalent Antivenom Production Market Share (2018-2023)
    Table 42. Rest of World Based Polyvalent Antivenom Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Polyvalent Antivenom Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Polyvalent Antivenom Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Polyvalent Antivenom Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Polyvalent Antivenom Production Market Share (2018-2023)
    Table 47. World Polyvalent Antivenom Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Polyvalent Antivenom Production by Type (2018-2023) & (K Units)
    Table 49. World Polyvalent Antivenom Production by Type (2024-2029) & (K Units)
    Table 50. World Polyvalent Antivenom Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Polyvalent Antivenom Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Polyvalent Antivenom Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Polyvalent Antivenom Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Polyvalent Antivenom Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Polyvalent Antivenom Production by Application (2018-2023) & (K Units)
    Table 56. World Polyvalent Antivenom Production by Application (2024-2029) & (K Units)
    Table 57. World Polyvalent Antivenom Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Polyvalent Antivenom Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Polyvalent Antivenom Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Polyvalent Antivenom Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. CSL Basic Information, Manufacturing Base and Competitors
    Table 62. CSL Major Business
    Table 63. CSL Polyvalent Antivenom Product and Services
    Table 64. CSL Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. CSL Recent Developments/Updates
    Table 66. CSL Competitive Strengths & Weaknesses
    Table 67. Merck Basic Information, Manufacturing Base and Competitors
    Table 68. Merck Major Business
    Table 69. Merck Polyvalent Antivenom Product and Services
    Table 70. Merck Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Merck Recent Developments/Updates
    Table 72. Merck Competitive Strengths & Weaknesses
    Table 73. BTG Basic Information, Manufacturing Base and Competitors
    Table 74. BTG Major Business
    Table 75. BTG Polyvalent Antivenom Product and Services
    Table 76. BTG Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. BTG Recent Developments/Updates
    Table 78. BTG Competitive Strengths & Weaknesses
    Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 80. Pfizer Major Business
    Table 81. Pfizer Polyvalent Antivenom Product and Services
    Table 82. Pfizer Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Pfizer Recent Developments/Updates
    Table 84. Pfizer Competitive Strengths & Weaknesses
    Table 85. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 86. Haffkine Bio-Pharmaceutical Major Business
    Table 87. Haffkine Bio-Pharmaceutical Polyvalent Antivenom Product and Services
    Table 88. Haffkine Bio-Pharmaceutical Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Haffkine Bio-Pharmaceutical Recent Developments/Updates
    Table 90. Haffkine Bio-Pharmaceutical Competitive Strengths & Weaknesses
    Table 91. Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 92. Rare Disease Therapeutics Major Business
    Table 93. Rare Disease Therapeutics Polyvalent Antivenom Product and Services
    Table 94. Rare Disease Therapeutics Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Rare Disease Therapeutics Recent Developments/Updates
    Table 96. Rare Disease Therapeutics Competitive Strengths & Weaknesses
    Table 97. Flynn Pharma Basic Information, Manufacturing Base and Competitors
    Table 98. Flynn Pharma Major Business
    Table 99. Flynn Pharma Polyvalent Antivenom Product and Services
    Table 100. Flynn Pharma Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Flynn Pharma Recent Developments/Updates
    Table 102. Flynn Pharma Competitive Strengths & Weaknesses
    Table 103. Vins Bioproducts Basic Information, Manufacturing Base and Competitors
    Table 104. Vins Bioproducts Major Business
    Table 105. Vins Bioproducts Polyvalent Antivenom Product and Services
    Table 106. Vins Bioproducts Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Vins Bioproducts Recent Developments/Updates
    Table 108. Vins Bioproducts Competitive Strengths & Weaknesses
    Table 109. Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
    Table 110. Bharat Serums and Vaccines Major Business
    Table 111. Bharat Serums and Vaccines Polyvalent Antivenom Product and Services
    Table 112. Bharat Serums and Vaccines Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Bharat Serums and Vaccines Recent Developments/Updates
    Table 114. Bharat Serums and Vaccines Competitive Strengths & Weaknesses
    Table 115. Serum Biotech Basic Information, Manufacturing Base and Competitors
    Table 116. Serum Biotech Major Business
    Table 117. Serum Biotech Polyvalent Antivenom Product and Services
    Table 118. Serum Biotech Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Serum Biotech Recent Developments/Updates
    Table 120. MicroPharm Basic Information, Manufacturing Base and Competitors
    Table 121. MicroPharm Major Business
    Table 122. MicroPharm Polyvalent Antivenom Product and Services
    Table 123. MicroPharm Polyvalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Polyvalent Antivenom Upstream (Raw Materials)
    Table 125. Polyvalent Antivenom Typical Customers
    Table 126. Polyvalent Antivenom Typical Distributors
List of Figure
    Figure 1. Polyvalent Antivenom Picture
    Figure 2. World Polyvalent Antivenom Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Polyvalent Antivenom Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Polyvalent Antivenom Production (2018-2029) & (K Units)
    Figure 5. World Polyvalent Antivenom Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Polyvalent Antivenom Production Value Market Share by Region (2018-2029)
    Figure 7. World Polyvalent Antivenom Production Market Share by Region (2018-2029)
    Figure 8. North America Polyvalent Antivenom Production (2018-2029) & (K Units)
    Figure 9. Europe Polyvalent Antivenom Production (2018-2029) & (K Units)
    Figure 10. China Polyvalent Antivenom Production (2018-2029) & (K Units)
    Figure 11. Japan Polyvalent Antivenom Production (2018-2029) & (K Units)
    Figure 12. Polyvalent Antivenom Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Polyvalent Antivenom Consumption (2018-2029) & (K Units)
    Figure 15. World Polyvalent Antivenom Consumption Market Share by Region (2018-2029)
    Figure 16. United States Polyvalent Antivenom Consumption (2018-2029) & (K Units)
    Figure 17. China Polyvalent Antivenom Consumption (2018-2029) & (K Units)
    Figure 18. Europe Polyvalent Antivenom Consumption (2018-2029) & (K Units)
    Figure 19. Japan Polyvalent Antivenom Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Polyvalent Antivenom Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Polyvalent Antivenom Consumption (2018-2029) & (K Units)
    Figure 22. India Polyvalent Antivenom Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Polyvalent Antivenom by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Polyvalent Antivenom Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Polyvalent Antivenom Markets in 2022
    Figure 26. United States VS China: Polyvalent Antivenom Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Polyvalent Antivenom Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Polyvalent Antivenom Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Polyvalent Antivenom Production Market Share 2022
    Figure 30. China Based Manufacturers Polyvalent Antivenom Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Polyvalent Antivenom Production Market Share 2022
    Figure 32. World Polyvalent Antivenom Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Polyvalent Antivenom Production Value Market Share by Type in 2022
    Figure 34. Antiviral Toxin-based Antivenom
    Figure 35. Anti - Neurotoxic Antivenom
    Figure 36. Anti - Mixed Venom Antivenom
    Figure 37. World Polyvalent Antivenom Production Market Share by Type (2018-2029)
    Figure 38. World Polyvalent Antivenom Production Value Market Share by Type (2018-2029)
    Figure 39. World Polyvalent Antivenom Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Polyvalent Antivenom Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Polyvalent Antivenom Production Value Market Share by Application in 2022
    Figure 42. Non-profit Institutions
    Figure 43. Hospitals and Clinic
    Figure 44. World Polyvalent Antivenom Production Market Share by Application (2018-2029)
    Figure 45. World Polyvalent Antivenom Production Value Market Share by Application (2018-2029)
    Figure 46. World Polyvalent Antivenom Average Price by Application (2018-2029) & (US$/Unit)
    Figure 47. Polyvalent Antivenom Industry Chain
    Figure 48. Polyvalent Antivenom Procurement Model
    Figure 49. Polyvalent Antivenom Sales Model
    Figure 50. Polyvalent Antivenom Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Polyvalent Antivenom Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Polyvalent Antivenom Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Pharma & Healthcare

Global Polyvalent Antivenom Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Polyvalent Antivenom Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Polyvalent Antivenom market size was valued at USD 591.6 million in 2023 and is forecast to a readjusted size of USD 779.6 million by 2030 with a CAGR of 4.0% during review period.

Global Polyvalent Antivenom Supply, Demand and Key Producers, 2024-2030

Global Polyvalent Antivenom Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Polyvalent Antivenom market size is expected to reach $ 779.6 million by 2030, rising at a market growth of 4.0% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>